Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role?
Abstract Purpose of Review Ulcerative colitis (UC) is a chronic inflammatory bowel disorder
that causes inflammation in the colon and rectum and can be lethal to the patients. The …
that causes inflammation in the colon and rectum and can be lethal to the patients. The …
Efficacy of topical versus oral 5-aminosalicylate for treatment of 2, 4, 6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats
J Li, C Chen, X Cao, G Wang, J Hu, J Wang - Journal of Huazhong …, 2014 - Springer
aminosalicylic acid (5-ASA) is drug of choice for the treatment of ulcerative colitis (UC). In
this study, the efficacy of topical versus oral 5-ASA for the treatment of UC was examined as …
this study, the efficacy of topical versus oral 5-ASA for the treatment of UC was examined as …
Similar pharmacokinetics of three dosing regimens comprising two oral delayed‐release mesalamine formulations in healthy adult volunteers: Randomised, open …
N Vande Casteele, A Jakate… - British Journal of …, 2021 - Wiley Online Library
Aims Mesalamine is the first‐line therapy for treating mild‐to‐moderate ulcerative colitis.
Multiple mesalamine formulations are available, with similar safety and efficacy profiles …
Multiple mesalamine formulations are available, with similar safety and efficacy profiles …
[HTML][HTML] 肠宁方灌肠联合美沙拉嗪对溃疡性直肠炎患者炎症因子及凝血功能的影响
谢海芳， 詹雅珍 - 世界华人消化杂志, 2017 - wjgnet.com
肠宁方灌肠联合美沙拉嗪对溃疡性直肠炎患者炎症因子及凝血功能的影响 主页 简体中文 English
简体中文 登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界 …
简体中文 登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界 …